Analystreport

Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at UBS Group AG from $125.00 to $121.00. They now have a "neutral" rating on the stock.

Edwards Lifesciences Corporation  (EW) 
Last edwards lifesciences corporation earnings: 4/23 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com